Profile: Auxilium Pharmaceuticals Inc (AUXL.OQ)

AUXL.OQ on NASDAQ Stock Exchange Global Select Market

19.65USD
1 Aug 2013
Price Change (% chg)

$1.29 (+7.03%)
Prev Close
$18.36
Open
$19.58
Day's High
$20.93
Day's Low
$18.65
Volume
788,685
Avg. Vol
203,044
52-wk High
$26.55
52-wk Low
$13.88

Search Stocks

Auxilium Pharmaceuticals, Inc., incorporated on July 23, 1999, is a specialty biopharmaceutical company. The Company focuses on developing and marketing products to predominantly specialist audiences. It market two products: Testim testosterone gel and XIAFLEX (collagenase clostridium histolyticum). XIAFLEX is an injectable clostridial collagenase enzyme approved by the United States Food and Drug Administration (FDA) for the treatment of Dupuytren's contracture (Dupuytren's) in adult patients with a palpable cord. The Company’s Testim is a topical 1% testosterone once-a-day gel that treats hypogonadism by restoring normal testosterone blood levels for a 24-hour period following application and sustaining them in that range when used daily. In April 2013, the Company acquired Actient Holdings LLC.

Testim has been approved for marketing for the indication of male hypogonadism in the United States, Canada, Belgium, Denmark, Finland, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden and the United Kingdom. XIAFLEX offers medical treatment option for physicians and patients who desire a minimally invasive alternative to surgery. The Company’s XIAFLEX is used for the treatment of Adhesive Capsulitis and edematous fibrosclerotic panniculopathy. BioSpecifics Technologies Corporation (BioSpecifics), from whom the Company has licensed worldwide rights to develop, market and sell certain products containing the collagenase enzyme, has conducted a Phase II clinical trial using CCH for the treatment of Frozen Shoulder syndrome.

The Company competes with AbbVie, Inc., Eli Lilly and Company, Endo Pharmaceuticals Inc., Actavis, Inc., Par Pharmaceutical Companies, Inc., Perrigo Israel Pharmaceuticals, Inc., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories, Inc., Halozyme Therapeutics, Repros Therapeutics, Inc. and Clarus Therapeutics, Inc.

Company Address

Auxilium Pharmaceuticals Inc

640 Lee Road
CHESTERBROOK   PA   19087
P: +1484.3215900
F: +1484.3215999

Search Stocks